Impact of a Novel Brain Longevity Supplement Containing the Postbiotic Urolithin A (Mitopure) on Cognitive Function and Related Health Outcomes (CLARITY)
Radicle Clarity™ 25_RAM: A Randomized, Double-Blind, Placebo-Controlled Direct-to-Consumer Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Health Outcomes
Sponsor: Amazentis SA
Listed as NCT07060898, this NA trial focuses on Aging and Brain Fog and remains ongoing. Sponsored by Amazentis SA, it has been updated 5 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Mar 2026 — Present [monthly]
Active Not Recruiting NA
Status: Completed → Active Not Recruiting
-
Jan 2026 — Mar 2026 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Oct 2025 — Jan 2026 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2025 — Oct 2025 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Aug 2025 — Sep 2025 [monthly]
Not Yet Recruiting NA
First recorded
Jul 2025
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Amazentis SA
- Radicle Science (sponsor)
For direct contact, visit the study record on ClinicalTrials.gov .